is semaglutide pills safe FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy GLP‑1 meds are reshaping obesity

The announcement comes at a time when many people are turning to online telehealth companies, which are manufacturing compounded versions of the weight loss drug as a cheaper alternative to name-brand GLP-1s like Zepbound

Across the full GLP-1 and obesity drug space, the post-2026 picture is a price-expansion wave led by Indian and Chinese biosimilars and by new dual or triple-agonist molecules, yet real uptake in the USA and EU will be shaped less by tariffs and more by regulatory timing, drug-device parity on pens and human-factors equivalence for AB-substitution, secondary IP and Orange Book hurdles, and payer or formulary contracting

It should not be interpreted as usage advice, preparation guidance, administration guidance or personal-use guidance

When it comes to GLP-1 therapy, the benefits often outweigh the risks